Prevention of cardiovascular events by antiplatelet agents after acute coronary syndrome - AReMIS
Study identifier:NIS-CFR-BRI-2012/1
ClinicalTrials.gov identifier:NCT01952392
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Study on the prevention of cardiovascular events by antiplatelet agents after acute coronary syndrome
Medical condition
Acute Coronary Syndrome
Phase
N/A
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
4992
Study type
Observational
Age
18 Years - 130 Years
Date
Study Start Date: 01 Oct 2013
Primary Completion Date: 01 Mar 2016
Study Completion Date: 01 Mar 2016
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Feb 2017 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Control group Patients aged 18 years or more with an acute coronary syndrome, agreed to participate and able to answer an interview in French and/or providing the details of an alternative replier (proxy) if necessary | - |
| Case group Patients aged 18 years or more with a history of acute coronary syndrome (i.e. a recurrent MI after myocardial history or unstable angina), agreed to participate and able to answer an interview in French and/or providing the details of an alternative replier (proxy) if necessary | - |
